BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioAtla's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 21.1% from the year before. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +21.1% |
| FY2024 | Dec 31, 2024 | 1M | +1.7% |
| FY2023 | Dec 31, 2023 | 1M | +22.7% |
| FY2022 | Dec 31, 2022 | 1M | +12.6% |
| FY2021 | Dec 31, 2021 | 1M | +310.1% |
| FY2020 | Dec 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2M | +42.0% |
| Q1 FY2026 | Mar 31, 2026 | 2M | +28.9% |
| Q4 FY2025 | Dec 31, 2025 | 1M | +20.4% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +21.5% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +21.3% |
| Q1 FY2025 | Mar 31, 2025 | 1M | +21.1% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +1.1% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +1.1% |
| Q4 FY2023 | Dec 31, 2023 | 1M | +10.5% |
| Q3 FY2023 | Sep 30, 2023 | 1M | +27.5% |
| Q2 FY2023 | Jun 30, 2023 | 1M | +27.5% |
| Q1 FY2023 | Mar 31, 2023 | 1M | +27.5% |
| Q4 FY2022 | Dec 31, 2022 | 1M | +17.5% |
| Q3 FY2022 | Sep 30, 2022 | 1M | +10.6% |
| Q2 FY2022 | Jun 30, 2022 | 1M | +11.1% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +11.0% |
| Q4 FY2021 | Dec 31, 2021 | 1M | -54.3% |
| Q3 FY2021 | Sep 30, 2021 | 1M | – |
| Q2 FY2021 | Jun 30, 2021 | 1M | – |
| Q1 FY2021 | Mar 31, 2021 | 1M | – |
| Q3 FY2020 | Sep 30, 2020 | 2M | – |
See a number that looks wrong?